Wichita KS 冠状动脉疾病临床试验
7项针对 冠状动脉疾病的研究正在 Wichita及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
招募中4 期
- Kansas Nephrology Physicians, PA, Wichita
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
招募中2/3 期
- Kansas Nephrology Physicians, PA, Wichita
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
招募中
- Ascension Via Christi Hospitals Wichita, Wichita
Virtue® SAB in the Treatment of Coronary ISR Trial
招募中
- Ascension Via Christi Saint Francis, Wichita
Prevail Global Study
招募中
- Ascension Via Christi Saint Francis, Wichita
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
招募中
- Cardiovascular Research Institute of Kansas, Wichita
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
招募中
- Cardiovascular Research Institute of Kansas, Wichita
其他城市的 冠状动脉疾病试验
- New York City, NY21 项研究
- Boston, MA16 项研究
- Dallas, TX15 项研究
- Atlanta, GA15 项研究
- Jacksonville, FL14 项研究
- Minneapolis, MN13 项研究
- Cleveland, OH13 项研究
- Nashville, TN11 项研究
- Columbus, OH10 项研究
- Durham, NC9 项研究
- Los Angeles, CA8 项研究
- Philadelphia, PA8 项研究
Wichita的其他研究
- 肥胖症11 项研究
- 2型糖尿病10 项研究
- 超重8 项研究
- 心力衰竭8 项研究
- 高血压8 项研究
- 乳腺癌5 项研究
- 主动脉瓣狭窄5 项研究
- 非小细胞肺癌5 项研究
- 肺癌5 项研究
- 结直肠癌4 项研究
- 心血管疾病4 项研究
- 糖尿病3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。